View in EDS HTML Full Text PDF Full Text

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.

Saved in:
Bibliographic Details
Title: Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.
Authors: Guo, Tongxuan1,2 (AUTHOR), Wu, Changyong1,2 (AUTHOR), Zhou, Lingni1,2 (AUTHOR), Zhang, Junhao1 (AUTHOR), Wang, Wanzhou1 (AUTHOR), Shen, Yang1 (AUTHOR), Zhang, Ludong1 (AUTHOR), Niu, Mingshan3 (AUTHOR), Zhang, Xu1,2 (AUTHOR) zhangxu0502@sina.com, Yu, Rutong1,2 (AUTHOR) yu.rutong@163.com, Liu, Xuejiao1,2 (AUTHOR) liuxuejiao0923@xzhmu.edu.cn
Source: Journal of Translational Medicine. 9/22/2023, Vol. 21 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-023-04332-y